Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
Ozone Prevents Cochlea Damage from Ischem�±a/Reperfus�±on Injury In Gu�±nea P�±gs
International Conference and Expo on Biopharmaceutics
Merih Onal, Cagdas Elsurer, Nebil Selimoglu, Mustafa Yilmaz, Ender Erdogan, Jale Bengi Celik and Ozkan Onal
Meram Educational and Training Hospital Department of Otolaryngology, Turkey
Selcuk University Medical Faculty Department of Otolaryngology, Turkey
Meram Educational and Training Hospital Department of Plastic Surgery, Turkey
Selcuk University Med
Introduction: The cochlea is a metabolically endorgan dependent on nutrient and oxygen supply to maintain its normal physiological
function. It is very sensitive to alterations in blood circulation that transient ischemia of the cochlea may result in common otologic
disorders. Cochlear ischemia and reperfusion injury has been considered one of the most important causes of human idiopathic
sudden sensorineural hearing loss. Ozone is a method in which a gas combination containing ozone and oxygen has been used
as a therapeutic agent for the treatment of many diseases. Ozone treatment creates resistance against oxidative stress by inducing
antioxidant systems. This research has been conducted to study the efficacy of ozone therapy against cochlear damage because of
ischemia and reperfusion, to investigate the potential clinical use of this treatment for sudden deafness. We evaluated cochlear
histology and the biochemical parameters characterizing the oxidative stress under ozone treatment.
Material and Method: 28 guinea pigs were randomized into four groups. Control group (n:7) was administered SF intraperitoneally
seven days without creating ischemia reperfusion injury and at eight day the guinea pigs were sacrified. Ozone group (n:7) was
administered 1 mg/kg ozone intraperitoneally for seven days without creating ischemia reperfusion. 1 mg/kg ozone was administered
intraperitoneally for seven days before IR injury in Ischemia Reperfusion (IR)+ Ozone group (I/R+O) (n:7) and at eighth day, these
guinea pigs were subjected to cochlear ischemia for 15 minutes by occluding left vertebral artery with a nontraumatic clamp and
then reperfusion for two hours. Ischemia Reperfusion (IR) group were subjected to cochlear ischemia for 15 minutes by occluding
left vertebral artery without ozone therapy. After the ischemia/reperfusion procedure, guinea pigs were sacrified at the same day.
For general histological evaluation, cochlear and spiral ganglionic tissues were examined with a light microscope and apoptotic
cells were counted with TUNEL (Terminal deoxynucleotidyl transferase dUTP nick end labeling) staining and apoptotic index
(AI) was calculated. Blood samples were sent for superoxide dismutase (SOD), glutation peroxidase (GSH-Px), catalase(CAT),
malondyaldehide (MDA), total oxidant score (TOS) and total antioxidant capacity (TAC) analysis. Data were evaluated statistically
by Kruskal Wallis test.
Results: In ischemia-reperfusion group, the degree of apoptotic index was found highest and statistically significantly compared to
the other groups (p<0.05). In the group ischemia reperfusion+ozone (IR+O), apoptotic index was found to be lower in comparison to
ischemia reperfusion (IR) group (p<0.05). Antioxidant parameters like SOD, GPX, TAC values were found to be increased in ozone
group and lowest in IR group (p<0.05). MDA and TOS oxidant parameters were found to be highest in IR group and decreased in
ozone group (p<0.05) .
Discussion: Controlled ozone administration was able to stimulate the endogenous antioxidant defense systems and could prepare
the host to face ischemia reperfusion injury. Ozone oxidative preconditioning may prevent ischemic tissue reperfusion injury. In
the present study, we found a statistically significant decrease in cochlear ischemia reperfusion damage with ozone therapy. Further
studies will be necessary to explain the protective mechanisms of ozone therapy on cochlear IR injury.